logo-loader
viewInnoCan Pharma

InnoCan Pharma looking at their CBD by injection technology as a game changer

InnoCan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive in Toronto to talk about the CBDcompnay and some of their interesting technology including the development of CBD by Injection.

Bincovich also told Proactive about their topical vertical that will focus on pain relief.

Quick facts: InnoCan Pharma

Price: 0.21 CAD

CSE:INNO
Market: CSE
Market Cap: $30.21 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of InnoCan Pharma named herein, including the promotion by the Company of InnoCan Pharma in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Innocan Pharma received U.S. FDA approval for their over the counter CBD...

Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has just received FDA approval in the United States for their patent-pending CBD Relief &GO pain relief collection. Bincovich talks about the collection and when they would...

2 weeks, 1 day ago

2 min read